Skip to content

REDPOINT BIO CORP: 10-Q filed 2012-05-21

What REDPOINT BIO CORP reported in its quarterly report filed 2012-05-21 (fiscal Q1 2012): 22 published measures, 59 facts as tagged in accession 0001144204-12-031038.

This filing

Form
10-Q (quarterly report)
Filed
2012-05-21
Fiscal period
fiscal Q1 2012
Accession
0001144204-12-031038 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REDPOINT BIO CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-03-3194,221USD
At 2011-12-31137,156USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-03-31499,148USD
At 2011-12-31469,263USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-03-31-404,927USD
At 2011-12-31-332,107USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-03-3168,267USD
At 2011-12-31126,724USD
At 2011-03-31553,279USD
At 2010-12-311,082,999USD
At 1995-08-150USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-82,590USD91
1995-08-16 to 2012-03-31-53,913,067USD6073
2011-01-01 to 2011-03-31-887,168USD90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-03-310USD91
1995-08-16 to 2012-03-313,380,219USD6073
2011-01-01 to 2011-03-310USD90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-03-310USD91
1995-08-16 to 2012-03-31-1,498,010USD6073
2011-01-01 to 2011-03-31-410,726USD90

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-03-319,770USD91
1995-08-16 to 2012-03-314,944,280USD6073
2011-01-01 to 2011-03-31118,344USD90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-86,952USD91
1995-08-16 to 2012-03-31-54,862,508USD6073
2011-01-01 to 2011-03-31-1,272,410USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-03-3194,221USD
At 2011-12-31137,156USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-03-310USD91
1995-08-16 to 2012-03-313,841,656USD6073
2011-01-01 to 2011-03-3125,495USD90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-03-31499,148USD
At 2011-12-31469,263USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-03-31384,479USD
At 2011-12-31372,904USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2012-01-01 to 2012-03-310USD91
1995-08-16 to 2012-03-31283,121USD6073
2011-01-01 to 2011-03-310USD90

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-03-3186,952USD91
1995-08-16 to 2012-03-3168,961,989USD6073
2011-01-01 to 2011-03-311,272,410USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-03-310USD91
1995-08-16 to 2012-03-3138,130,920USD6073
2011-01-01 to 2011-03-31625,930USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-03-3179,914,879shares
At 2011-12-3179,914,879shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-03-3161,810USD
At 2011-12-3143,500USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-03-3125,954USD
At 2011-12-3110,432USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-82,590USD91
1995-08-16 to 2012-03-31-55,411,077USD6073
2011-01-01 to 2011-03-31-1,297,894USD90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-03-3186,952USD91
1995-08-16 to 2012-03-3130,831,069USD6073
2011-01-01 to 2011-03-31646,480USD90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-03-3115,937USD91
1995-08-16 to 2012-03-311,492,930USD6073
2011-01-01 to 2011-03-31147,707USD90

Inspect the source

Entity
REDPOINT BIO CORP / CIK 0001328003
Captured
SEC response SHA-256
ecfc5d113443b9a026d38a0778b52ff2b0efdd07d9400844ef023d75edf90e9b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001328003.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))